Healthcare -
Biotechnology - NASDAQ - US
$ 3.715
5.84 %
$ 318 M
Market Cap
-0.97
P/E
AMLX - TOTAL EQUITY
Total Equity AMLX - Amylyx Pharmaceuticals, Inc.
433 M
LAST VALUE
120.62%
2 YEAR CAGR
0.00%
5 YEAR CAGR
0.00%
10 YEAR CAGR